Efaroxan
Efaroxan is a potent, selective and orally active α2-adrenoceptor antagonist, with antidiabetic activity. Efaroxan is a selective I1-Imidazoline receptor antagonist. Efaroxan can be used for the research of cardiovascular disease[1][2][3].
Product Specifications
CAS Number
89197-32-0
UNSPSC
12352005
Target
Adrenergic Receptor; Imidazoline Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Cardiovascular Disease; Metabolic Disease
Smiles
CCC1(C2=NCCN2)OC3=CC=CC=C3C1
Molecular Formula
C13H16N2O
Molecular Weight
216.28
References & Citations
[1]Berridge TL, et al. Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat. Eur J Pharmacol. 1992 Mar 24;213 (2) :205-12. |[2]A O Abdel-Zaher, et al. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists. Pharmacol Res. 2001 Nov;44 (5) :397-409.|[3]T L Berridge, et al. Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in rats. Eur J Pharmacol. 1992 Mar 24;213 (2) :213-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AZQ6NZ09-Biotin 100 µg/Vial
Anti-Zebrafish ADRM1 Antibody Picoband® Biotin Conjugated
Sign In for Pricing
View Details 
100821Y1-AAT 100 Tests
PE/iFluor® 594 Anti-human CD8 Antibody *OKT-8*
Sign In for Pricing
View Details bs-1728R-BF594-01 20 µL
CX3CR1 Polyclonal Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details